|
1
|
Mullighan CG, Goorha S, Radtke I, Miller
CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds
SB, et al: Genome-wide analysis of genetic alterations in acute
lymphoblastic leukaemia. Nature. 446:758–764. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuiper RP, Schoenmakers EF, van
Reijmersdal SV, Hehir-Kwa JY, van Kessel AG, van Leeuwen FN and
Hoogerbrugge PM: High-resolution genomic profiling of childhood ALL
reveals novel recurrent genetic lesions affecting pathways involved
in lymphocyte differentiation and cell cycle progression. Leukemia.
21:1258–1266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harvey RC, Mullighan CG, Wang X, Dobbin
KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, et
al: Identification of novel cluster groups in pediatric high-risk
B-precursor acute lymphoblastic leukemia with gene expression
profiling: Correlation with genome-wide DNA copy number
alterations, clinical characteristics, and outcome. Blood.
116:4874–4884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roberts KG and Mullighan CG: Genomics in
acute lymphoblastic leukaemia: Insights and treatment implications.
Nat Rev Clin Oncol. 12:344–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schwab CJ, Jones LR, Morrison H, Ryan SL,
Yigittop H, Schouten JP and Harrison CJ: Evaluation of multiplex
ligation-dependent probe amplification as a method for the
detection of copy number abnormalities in B-cell precursor acute
lymphoblastic leukemia. Genes Chromosomes Cancer. 49:1104–1113.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schouten JP, McElgunn CJ, Waaijer R,
Zwijnenburg D, Diepvens F and Pals G: Relative quantification of 40
nucleic acid sequences by multiplex ligation-dependent probe
amplification. Nucleic Acids Res. 30:e572002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao X, Wie H, Lin D, Wang Y, Zhou C, Liu
B, Li W, Liu K, Wang H, Li C, et al: Optimal treatment of adult Ph
negative acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi.
35:873–879. 2014.(In Chinese). PubMed/NCBI
|
|
8
|
Fang Q, Zhao X, Li Q, Li Y, Liu K, Tang K,
Wang Y, Liu B, Wang M, Xing H, et al: IKZF1 alterations and
expressions of CRLF2 predict prognosis in Chinese adult patients
with B-cell precursor acute lymphoblastic leukemia. Leuk Lymphoma.
58:127–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gökbuget N and Hoelzer D: Treatment of
adult acute lymphoblastic leukemia. Semin Hematol. 46:64–75. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ofverholm I, Tran AN, Heyman M,
Zachariadis V, Nordenskjöld M, Nordgren A and Barbany G: Impact of
IKZF1 deletions and PAX5 amplifications in pediatric B-cell
precursor ALL treated according to NOPHO protocols. Leukemia.
27:1936–1939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moorman AV, Enshaei A, Schwab C, Wade R,
Chilton L, Elliott A, Richardson S, Hancock J, Kinsey SE, Mitchell
CD, et al: A novel integrated cytogenetic and genomic
classification refines risk stratification in pediatric acute
lymphoblastic leukemia. Blood. 124:1434–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krentz S, Hof J, Mendioroz A, Vaggopoulou
R, Dörge P, Lottaz C, Engelmann JC, Groeneveld TW, Körner G, Seeger
K, et al: Prognostic value of genetic alterations in children with
first bone marrow relapse of childhood B-cell precursor acute
lymphoblastic leukemia. Leukemia. 27:295–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan T, Zhao XL, Zhang LX, Li QH, Tian Z,
Tang KJ, Wang Y, Lin D, Li W, Liu BC, et al: Expression and
clinical significance of IKZF1 gene IK6 isoforms in adult acute
lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
21:539–543. 2013.(In Chinese). PubMed/NCBI
|
|
14
|
Yamashita Y, Shimada A, Yamada T, Yamaji
K, Hori T, Tsurusawa M, Watanabe A, Kikuta A, Asami K, Saito AM and
Horibe K: IKZF1 and CRLF2 gene alterations correlate with poor
prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor
acute lymphoblastic leukemia. Pediatr Blood Cancer. 60:1587–1592.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ribera J, Morgades M, Zamora L, Montesinos
P, Gómez-Seguí I, Pratcorona M, Sarrà J, Guàrdia R, Nomdedeu J,
Tormo M, et al: Prognostic significance of copy number alterations
in adolescent and adult patients with precursor B acute
lymphoblastic leukemia enrolled in PETHEMA protocols. Cancer.
121:3809–3817. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iacobucci I, Ferrari A, Lonetti A,
Papayannidis C, Paoloni F, Trino S, Storlazzi CT, Ottaviani E,
Cattina F, Impera L, et al: CDKN2A/B alterations impair prognosis
in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
Clin Cancer Res. 17:7413–7423. 2011. View Article : Google Scholar : PubMed/NCBI
|
